Hematologic aspects of human immunodeficiency virus infection: laboratory and clinical considerations.
Hematologic abnormalities are common in patients with HIV infection. This review will focus on HIV-associated cytopenias and coagulation abnormalities. Their occurrence, laboratory evaluation, and clinical significance and the mechanisms underlying their development are discussed. Therapeutic modalities are presented, with an emphasis on treatment strategies for HIV-associated thrombocytopenia.
D000163:Acquired Immunodeficiency Syndrome / Q000097:blood / Q000150:complications*; D000740:Anemia / Q000150:complications; D001696:Biomechanical Phenomena; D001779:Blood Coagulation Factors / Q000032:analysis / Q000276:immunology; D001855:Bone Marrow Diseases / Q000150:complications; D004913:Erythrocytes, Abnormal / Q000473:pathology; D006402:Hematologic Diseases / Q000150:complications* / Q000188:drug therapy / Q000628:therapy; D006801:Humans; D007165:Immunosuppression Therapy; D007962:Leukocytes / Q000473:pathology; D007970:Leukopenia / Q000150:complications; D016682:Lupus Coagulation Inhibitor; D013156:Splenectomy; D013921:Thrombocytopenia / Q000150:complications
D001779:Blood Coagulation Factors; D016682:Lupus Coagulation Inhibitor